Suven Life Sciences share price has zoomed 6% and is presently trading at Rs 126.0.
Meanwhile, the BSE HEALTHCARE index is at 42,990.8 .
Among the top gainers in the BSE HEALTHCARE index today are POLY MEDICURE (up 1.9%) and CAPLIN POINT (up 1.4%).
AJANTA PHARMA (down 1.9%) and KIMS (down 1.9%) are among the top losers today.
Over the last one year, Suven Life Sciences has moved up from Rs 84.3 to Rs 126.0, registering a gain of Rs 41.8 (up 49.6%).
On the other hand, the BSE HEALTHCARE index has moved up from 29,654.9 to 42,990.8, registering a gain of 45.0% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 164.8%), Glenmark Pharma (up 96.9%) and SUVEN PHARMACEUTICALS (up 94.4%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 80,248.8 .
The top gainers among the BSE Sensex today are MUNDRA PORT & SEZ (up 1.4%) and HDFC Bank (up 1.2%). The most traded stocks in the BSE Sensex are MUNDRA PORT & SEZ and Axis Bank.
In the meantime, NSE Nifty is at 24,296.5 (up 0.1%). Adani Enterprises and Shriram Transport are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 66,174.2 to 80,248.8, registering a gain of 14,074.6 points (up 21.3%).
Suven Life Sciences net profit fell 291.5% YoY to Rs -496 million for the quarter ended September 2024, compared to a loss of Rs 127 million a year ago. Net sales declined 15.9% to Rs 26 million during the period as against Rs 31 million in July-September 2023.
For the year ended March 2024, Suven Life Sciences reported 11.2% increase in net profit to Rs -1,051 million compared to net loss of Rs 1,183 million during FY23. Revenue of the company fell 13.6% to Rs 117 million during FY24.
The current Price to earnings ratio of Suven Life Sciences, based on rolling 12 month earnings, stands at -18.8.
Equitymaster requests your view! Post a comment on "Suven Life Sciences Gains 6%; BSE HEALTHCARE Index Down 0.0%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!